Bar-Ilan University scientist part of €8 million consortium to ensure accuracy in CAR-T cell therapy, an immunotherapy using CRISPR-Cas9, in European hospitals
The post Israeli researcher joins EU cell therapy initiative for blood cancers and tumors appeared first on The Times of Israel.
